9° Conferenza internazionale IAS sull’HIV

Dal 23 al 26 luglio 2017 si terrà a Parigi, in Francia, la 9° Conferenza internazionale per la ricerca sull’HIV (IAS 2017) organizzata dall’International AIDS Society.

NAM è lieta di essere partner ufficiale per la copertura scientifica online di IAS 2017.

Come tale, riferirà sui temi chiave presentati alla Conferenza pubblicando resoconti online alla pagina web www.aidsmap.com/ias2017

Bollettini

  • Giovedì 3 agosto 2017 (HTML | PDF)
  • Giovedì 27 luglio 2017 (HTML | PDF)
  • Mercoledì 26 luglio 2017 (HTML | PDF)
  • Martedì 25 luglio 2017 (HTML | PDF)
  • Lunedì 24 luglio 2017 (HTML | PDF)

Sign up today

Sign up for our free email bulletins:

NAM's news coverage of the International AIDS Society's Conference on HIV Science has been made possible thanks to support from Gilead Sciences Europe Ltd. and Merck & Co. NAM's wider conference news reporting services have been supported by Janssen and ViiV Healthcare.

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.